Fortress Biotech, Inc. · NASDAQ:FBIO
Integrated Core Strategies (US) LLC reported a 6.50% stake in Fortress Biotech, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 29, 2026
Integrated Core Strategies (US) LLC reported a 6.50% stake in Fortress Biotech, Inc., 2,165,122 shares, as a passive investor on Sep 30, 2026. Filed Oct 29, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 2,165,122
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 6.50% | 2,165,122 |
| Millennium Management LLC | 6.50% | 2,165,401 |
| Millennium Group Management LLC | 6.50% | 2,165,401 |
| Israel A. Englander | 6.50% | 2,165,401 |
Source
Download original · View original at SEC
Related
- Fortress Biotech, Inc.
- Millennium Management LLC
- Fortress Biotech, Inc. shareholders
- Schedule 13G · Millennium Management LLC · Sep 1, 2026
- Form 4 · Rosenwald Lindsay A Md · Nov 19, 2026
- Form 4 · Jin David · Nov 19, 2026
- Form 4 · Jin David · Oct 1, 2026
- Form 4 · Jin David · Jun 24, 2026
- Schedule 13G/A · Highbridge Capital Management LLC · May 15, 2026